http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014005597-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9b8119aee193c3600e46b92d2019fee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4588017dced805561661d462711351a0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00792
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
filingDate 2013-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d0f9e6ada4d8b0f17f0d9d7ba4e9173
publicationDate 2014-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014005597-A1
titleOfInvention Kit and method for use in administering therapeutic botulinum toxin (botox)
abstract A preassembled kit organizes the administration of therapeutic botulinum toxin by providing all of the important ingredients necessary for the procedure, including a vial of botulinum toxin preserved on dry ice. The kit also includes saline solution sufficient to dilute the botulinum toxin; a syringe to inject the saline solution into the vial of botulinum toxin; one or more needles to administer the diluted botulinum toxin; and other items associated with the procedure. Such items may include a plurality of absorbent pads, a patient gown, and clinician gloves. Particularly for use in the administration of therapeutic botulinum toxin, the kit may further include at least one radiolucent electrode, and at least one needle adapted for connection to a nerve stimulator.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018236873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2922287-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015140092-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016151241-A1
priorityDate 2012-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012271275-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010204694-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727

Total number of triples: 35.